Product Information
ROSYRAH TABLET is a generic product labeled by Xiromed LLC, priced at $1.5932 per EA under NDC 70700031287. Its NADAC has been published 22 times since Jul 9, 2025.
Manufacturer
Xiromed LLCNDC
70700031287
Classification
Generic
Dosage Form
KIT
Route
ORAL
Last Updated
6/17/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA206053On Market Since
1/29/2025
Price Statistics
The NADAC for ROSYRAH TABLET has been published 22 times since Jul 9, 2025, and over the history we have for it it has risen 30.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5932 per EA |
|---|---|
| All-time high | $1.7000 (Jun 10, 2026) |
| All-time low | $1.2238 (Jul 9, 2025) |
| 52-week high | $1.7000 |
| 52-week low | $1.2238 |
| Median price | $1.2803 |
| Average price | $1.3808 |
| Largest weekly change | +32.8% (May 20, 2026) |
| Weeks tracked | 22 |
| Tracking since | Jul 9, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ROSYRAH TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROSYRAH TABLET, manufactured by Xiromed LLC, is $1.5932 per EA (NDC 70700031287), effective Jun 24, 2026.
How has the price of ROSYRAH TABLET changed over time?
Over the history we have for it, the NADAC for ROSYRAH TABLET has risen 30.2%. It has been tracked across 22 weekly CMS publications since Jul 9, 2025.
What are the highest and lowest recorded NADAC prices for ROSYRAH TABLET?
Since Jul 9, 2025, the NADAC for ROSYRAH TABLET has ranged from a low of $1.2238 (Jul 9, 2025) to a high of $1.7000 (Jun 10, 2026), with a median of $1.2803 per EA.
Are there cheaper alternatives to ROSYRAH TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as ROSYRAH TABLET, but none are currently priced below it.
Who manufactures ROSYRAH TABLET?
ROSYRAH TABLET (NDC 70700031287) is labeled by Xiromed LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification